Literature DB >> 2826030

Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

R G Olsen1, M G Lewis, L J Lafrado, L E Mathes, K Haffer, R Sharpee.   

Abstract

This is a review of the current knowledge of feline leukemia virus (FeLV) associated with immune depression observed in cats. It will focus on the clinical and experimental observations associated with feline retroviral infection and presence in vivo and in vitro. We will briefly describe retroviral-associated acquired immune deficiency syndrome associated with FeLV infection in the cat and specific cellular pathology associated with FeLV latency. In addition, we will focus on the action of FeLV-p15E in vitro and describe possible mechanisms of the FeLV-associated immunosuppression observed both in vivo and in vitro. Lastly, we will evaluate the current status of immunoprevention of FeLV. We will not attempt an in-depth analysis of the current literature; our focus is to review current findings as they relate to feline AIDS and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826030     DOI: 10.1007/BF00144266

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  111 in total

1.  Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodies.

Authors:  F de Noronha; R Baggs; W Schäfer; D Bolognesi
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

2.  Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.

Authors:  E A Hoover; S Krakowka; G L Cockerell; L E Mathes; R G Olsen
Journal:  Am J Vet Res       Date:  1978-06       Impact factor: 1.156

3.  Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses.

Authors:  R A Harrell; G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

5.  Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion.

Authors:  L J Anderson; W F Jarrett; O Jarrett; H M Laird
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

6.  Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas.

Authors:  G S Payne; J M Bishop; H E Varmus
Journal:  Nature       Date:  1982-01-21       Impact factor: 49.962

7.  Vaccination against feline leukaemia virus using a cell membrane antigen system.

Authors:  W Jarrett; O Jarrett; L Mackey; H Laird; C Hood; D Hay
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

8.  Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.

Authors:  C G Orosz; N E Zinn; R G Olsen; L E Mathes
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat.

Authors:  G L Cockerell; E A Hoover; S Krakowka; R G Olsen; D S Yohn
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

10.  Protection against feline leukemia by vaccination with a subunit vaccine.

Authors:  M G Lewis; L E Mathes; R G Olsen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more
  5 in total

1.  Tumor cells expressing a retroviral envelope escape immune rejection in vivo.

Authors:  M Mangeney; T Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 2.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

3.  High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings.

Authors:  M Suntz; K Failing; W Hecht; D Schwartz; M Reinacher
Journal:  Vet Immunol Immunopathol       Date:  2010-03-25       Impact factor: 2.046

Review 4.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03

Review 5.  Immune mechanisms in the pathogenesis of viral diseases: a review.

Authors:  G Trautwein
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.